FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMENT OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: MAY 22, 2016

Results 251 through 261 of 261

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
VTAE Nasdaq Vitae Pharmaceuticals Inc 2834
VTVT Nasdaq vTv Therapeutics Inc 2834
VVUS Nasdaq VIVUS, Inc. 2834
WNDM Over the counter Wound Management Technologies 2834
XENE Nasdaq Xenon Pharmaceuticals Inc 2834
XNCR Nasdaq Xencor Inc 2834
XNPT Nasdaq XenoPort, Inc. 2834
XOMA Nasdaq XOMA Corp 2834
ZFGN Nasdaq Zafgen Inc 2834
ZGNX Nasdaq Zogenix, Inc. 2834
ZTS New York Zoetis Inc 2834
Results 250 through 261 of 261